In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue

Journal of Periodontal Research

Volumn 39, Issue 1, 2004, Pages 42-49

  Ogasawara, T ^a   Yoshimine, Y ^a   Kiyoshima, T ^a   Kobayashi, I ^a   Matsuo, K ^a   Akamine, A ^a   Sakai, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

In situ hybridization; Osteoclast; Periodontal tissue; Receptor activator of nuclear factor b ligand

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; ISOPROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARAFFIN; RNA; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; CELL RECEPTOR; CYTOKININ; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LIGAND; MEMBRANE PROTEIN; TNFRSF11B PROTEIN, RAT; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; CONTROLLED STUDY; FORCE; IN SITU HYBRIDIZATION; MALE; MANDIBLE; MAXILLA; NONHUMAN; ODONTOBLAST; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE CULTURE CELL; TOOTH EXTRACTION; ANIMAL; AUTOCRINE EFFECT; CELL COUNT; METABOLISM; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PERIODONTIUM; WISTAR RAT;

ANIMALS; AUTOCRINE COMMUNICATION; BONE RESORPTION; CARRIER PROTEINS; CELL COUNT; CYTOKININS; GLYCOPROTEINS; INTERLEUKIN-1; LIGANDS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; ODONTOBLASTS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; PERIODONTIUM; RANK LIGAND; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TOOTH MOVEMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542758223     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00699.x     Document Type: Article

References (27)

1. Anderson DM, Maraskovsky E, Billingsley WL et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
2. Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
3. Shalhoub V, Faust J, Boyle WJ et al. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem 1999;72:251-261.
4. Kobayashi K, Takahashi N, Jimi E et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-286.
5. Hasegawa T, Yoshimura Y, Kikuiri T et al. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodont Res 2002;37:405-411.
6. Kanzaki H, Chiba M, Shimizu Y et al. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factorκB ligand up-regulation via prostaglandin E2 systhesis. J Bone Miner Res 2002;17: 210-220.
7. Thomas GP, Baker SU, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 2001;170:451-460.
8. Waldo CM, Rothblatt JM. Histologic response to tooth movement in the laboratory rat. J Dent Res 1954;33:481-486.
9. Tanaka T, Morioka T, Ayasaka N, Iijima T, Kondo T. Endocytosis in odontoclasts and osteoclasts using microperoxidase as a tracer. J Dent Res 1990;69:883-889.
10. Yamaza H, Matsuo K, Kobayashi I et al. Expression of Set-alpha during morphogenesis of mouse lower first molar. Histochem J 2001;33:437-441.
11. Kartsogiammis V, Zhou H, Horwood NJ et al. Localization of RANKL (Receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 1999;25:525-534.
12. Ikeda T, Utsuyama M, Hirokawa K. Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 2001;16:1416-1425.
13. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
14. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001;276:20659-20672.
15. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNF alpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002;143: 1108-1118.
16. Romas E, Bakharevski O, Hards DK et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 2000 April;43:821-826.
17. + -ATPase, cathepsin K, matrix metalloproteinase-9, and receptor activator of NFkappaB ligand in odontoclasts during physiological root resorption of human deciduous teeth. Anat Rec 2002;264:305-311.
18. Shiotani A, Takami M, Itoh K, Shibasaki Y, Sasaki T. Regulation of osteoclast differentiation and function by receptor activator of NFκB ligand and osteoprotegerin. Anal Rec 2002;268:137-146.
19. Nakagawa N, Kinosaki M, Yamaguchi K et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998;253:395-400.
20. Myers DE, Collier FM, Minkin C et al. Expression of functional RANK on mature rat and human osteoclasts. FEBS Lett 1999;463:295-300.
21. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998;188:997-1001.
22. Ikeda T, Kasai M, Utsuyama M, Hirokawa K. Determination of three isoforms of the receptor activator of nuclear factor-κB ligand and their differentiation expression in bone and thymus. Endocrinology 2001;142:1419-1426.
23. Itoh K, Udagawa N, Kobayashi K et al. Lipopolysaccharide promotes the survival of osteoclasts via toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 2003;170:3688-33695.
24. Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res 1999;78:1617-1623.
25. Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA. Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation. J Pathol 2002;198:220-227.
26. O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest 1997;76:457-465.
27. Kanzaki H, Chiba M, Shimizu Y, Mitani H. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res 2002;17:210-220.